Contact
searchSearch
HMP Global
Login

May 2017

Research in Review
PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer
05/12/2017
New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...
New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...
New...
05/12/2017
Journal of Clinical Pathways
Research in Review
Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse B-Cell Lymphoma
05/12/2017
Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...
Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...
...
05/12/2017
Journal of Clinical Pathways
Research in Review
PD-1 Expression in T Cells Aids Immunotherapy Strategies for NSCLC
05/12/2017
Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to antitumor response for patients with non-small cell lung cancer (NSCLC), according to research published...
Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to antitumor response for patients with non-small cell lung cancer (NSCLC), according to research published...
...
05/12/2017
Journal of Clinical Pathways
Editor's Page
No Summer Vacation for Clinical Pathways
05/12/2017
Winston Wong, PharmD
Summer is a time for rest and relaxation, a chance to recharge after long and stressful winters. However, for medical professionals—particularly oncologists—the beginning of June is one of the more hectic times of...
Summer is a time for rest and relaxation, a chance to recharge after long and stressful winters. However, for medical professionals—particularly oncologists—the beginning of June is one of the more hectic times of...
Summer...
05/12/2017
Journal of Clinical Pathways
Research Reports
The Impact of a Multidisciplinary Care Coordination Protocol On Patient-Centered Outcomes at an Academic Medical Center
05/12/2017
Amit S. Dhamoon, MD, PhD; Chris Lau, MD
Abstract: Effective coordination of care has been associated with improved performance on patient-centered measures of care quality. A standardized protocol for conducting multidisciplinary rounds (MDR) can improve...
Abstract: Effective coordination of care has been associated with improved performance on patient-centered measures of care quality. A standardized protocol for conducting multidisciplinary rounds (MDR) can improve...
...
05/12/2017
Journal of Clinical Pathways
Research Reports
Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening
05/12/2017
Andrea Dwyer, BS; R. Mark Gritz, PhD; Yvonne Kellar-Guenther, PhD; Whitney C. Rhodes, PhD, MSPA; Arnold H. Levinson, PhD, MJ
Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...
Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...
...
05/12/2017
Journal of Clinical Pathways
Pharma Insights
What Does New Payer Research on Expected Biosimilar Management Mean to Others?
05/12/2017
Larry Blandford, PharmD
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...
...
05/12/2017
Journal of Clinical Pathways
Clinical Pathways GPS
The Next 1361 Days and How They Will Impact Clinical Pathways
05/12/2017
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over...
05/12/2017
Journal of Clinical Pathways
Interview
Palliative Care Claims Its Place in Oncology Practice
05/12/2017
Proper care choices for patients with advanced cancers remains an open question in the oncology community. Despite limited life expectancies, patients whose diseases have reached advanced states often continue to...
Proper care choices for patients with advanced cancers remains an open question in the oncology community. Despite limited life expectancies, patients whose diseases have reached advanced states often continue to...
...
05/12/2017
Journal of Clinical Pathways
Interview
Managing Costs Across the Cancer Care Continuum
05/12/2017
Few medical expenditures are costlier than a cancer diagnosis. Cancer-associated medical costs accounted for approximately $88 billion in health care spending in 2014, according to data from the Agency for...
Few medical expenditures are costlier than a cancer diagnosis. Cancer-associated medical costs accounted for approximately $88 billion in health care spending in 2014, according to data from the Agency for...
Few...
05/12/2017
Journal of Clinical Pathways
JCP July-Aug Cover 2025

Current Issue

August 2025
Volume 11
Issue 4
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

May 2017 Volume 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use